Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kees

Showing results (251-260 of 333) with videos related to

Pageof 34
Sort By:
The Lancet. Child & Adolescent Health|May 17, 2024
Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registriesM Doortje Reijman, Tycho R Tromp, Barbara A Hutten, et al.
Atherosclerosis|May 17, 2016
Targeted exonic sequencing of GWAS loci in the high extremes of the plasma lipids distributionAniruddh P Patel, Gina M Peloso, James P Pirruccello, et al.
Atherosclerosis|October 31, 2020
A neutralizing antibody against DKK1 does not reduce plaque formation in classical murine models of atherosclerosis: Is the therapeutic potential lost in translation?Günaj Rakipovski, Bidda Rolin, Natasha Barascuk, et al.
JAMA Cardiology|February 14, 2024
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial HypercholesterolemiaJanneke W C M Mulder, Tycho R Tromp, Mutaz Al-Khnifsawi, et al.
JAMA|September 3, 2019
Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular DiseaseBrian A Ference, Deepak L Bhatt, Alberico L Catapano, et al.
Lancet (London, England)|August 24, 2024
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trialJohn Deanfield, Subodh Verma, Benjamin M Scirica, et al.
Journal of Lipid Research|January 7, 2015
Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHARuud S Kootte, Loek P Smits, Fleur M van der Valk, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2020
Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape TownRoeland Huijgen, Dirk J Blom, Merel L Hartgers, et al.
Journal of the American College of Cardiology|October 4, 2014
Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemiaDiederik F van Wijk, Barbara Sjouke, Amparo Figueroa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 31, 2020
Taking One Step Back in Familial Hypercholesterolemia: <i>STAP1</i> Does Not Alter Plasma LDL (Low-Density Lipoprotein) Cholesterol in Mice and HumansNatalia Loaiza, Merel L Hartgers, Laurens F Reeskamp, et al.
Pageof 34

Showing results (251-260 of 333) with videos related to

Sort By:
Pageof 34
The Lancet. Child & Adolescent Health|May 17, 2024
Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registriesM Doortje Reijman, Tycho R Tromp, Barbara A Hutten, et al.
Atherosclerosis|May 17, 2016
Targeted exonic sequencing of GWAS loci in the high extremes of the plasma lipids distributionAniruddh P Patel, Gina M Peloso, James P Pirruccello, et al.
Atherosclerosis|October 31, 2020
A neutralizing antibody against DKK1 does not reduce plaque formation in classical murine models of atherosclerosis: Is the therapeutic potential lost in translation?Günaj Rakipovski, Bidda Rolin, Natasha Barascuk, et al.
JAMA Cardiology|February 14, 2024
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial HypercholesterolemiaJanneke W C M Mulder, Tycho R Tromp, Mutaz Al-Khnifsawi, et al.
JAMA|September 3, 2019
Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular DiseaseBrian A Ference, Deepak L Bhatt, Alberico L Catapano, et al.
Lancet (London, England)|August 24, 2024
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trialJohn Deanfield, Subodh Verma, Benjamin M Scirica, et al.
Journal of Lipid Research|January 7, 2015
Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHARuud S Kootte, Loek P Smits, Fleur M van der Valk, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2020
Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape TownRoeland Huijgen, Dirk J Blom, Merel L Hartgers, et al.
Journal of the American College of Cardiology|October 4, 2014
Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemiaDiederik F van Wijk, Barbara Sjouke, Amparo Figueroa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 31, 2020
Taking One Step Back in Familial Hypercholesterolemia: <i>STAP1</i> Does Not Alter Plasma LDL (Low-Density Lipoprotein) Cholesterol in Mice and HumansNatalia Loaiza, Merel L Hartgers, Laurens F Reeskamp, et al.
Pageof 34